Trillium Therapeutics Inc (TRIL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2007 | 09-2007 | 06-2007 | 03-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 73 | 81 | 71 | 61 | 54 |
| Accounts receivable | -70 | -25 | -31 | 6 | -2 |
| Other Working Capital | -146 | -39 | 33 | 128 | 279 |
| Other Operating Activity | -2,083 | -1,225 | -733 | -895 | -925 |
| Operating Cash Flow | $-2,226 | $-1,209 | $-660 | $-700 | $-594 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -13 | -14 | -4 | -6 | 0 |
| Investing Cash Flow | $-13 | $-14 | $-4 | $-6 | $1 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 11,107 | 268 | 291 | 3,304 | -2 |
| Other Financing Activity | -384 | 47 | -6 | -54 | 262 |
| Financing Cash Flow | $10,723 | $315 | $285 | $3,250 | $260 |
| Beginning Cash Position | 2,302 | 3,140 | 3,444 | 900 | 1,433 |
| End Cash Position | 10,870 | 2,302 | 3,140 | 3,444 | 890 |
| Net Cash Flow | $8,484 | $-908 | $-379 | $2,544 | $-334 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,226 | -1,209 | -660 | -700 | -594 |
| Capital Expenditure | -13 | -14 | -4 | -6 | N/A |
| Free Cash Flow | -2,239 | -1,223 | -664 | -706 | -594 |